Related Experiment Video
Updated: May 24, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Mast cell-driven remodeling of pulmonary immune and stromal landscapes in COVID-19
D A Atiakshin1,2, O A Burgasova3,4, A A Kostin3
1RUDN University, 6 Miklukho-Maklaya St, Moscow, Russia, 117198. atyakshin-da@rudn.ru.
Abstract:
The role of mast cells (MCs) in the pathogenesis of COVID-19 remains poorly understood. In the present study, we profiled the spatial phenotype of MC interaction with the pulmonary immune and stromal landscapes. The study included lung tissue samples from 12 COVID-19 patients and 12 patients with undifferentiated community-acquired pneumonia (CAP). Histochemical, monoplex, and multiplex immunohistochemical staining with spatial phenotyping, profiling, and mapping of MCs, as well as interactions with the immune and stromal landscape of the lungs, including elastic and collagen fibers, were used. Compared with other respiratory infections, SARS-CoV-2-associated pneumonia caused an increase in the pool of MCs in the lungs simultaneously with the activation of targeted secretion of tryptase and the formation of significant differences in the spatial phenotype of colocalization of MCs with immunocompetent cells and fibers. The intensity of juxtacrine and paracrine interactions of MC with cytotoxic lymphocytes and monocytes increased, initiating the polarization of macrophages into type 2. In this case, MCs and type 2 macrophages formed extended multicellular chains in the form of a functional syncytium, creating profibrotic niches of the local tissue microenvironment. Under COVID-19 conditions, an unexpected increase in MC interaction with elastic extracellular matrix (ECM) fibers and localized tryptase release revealed new insights into tissue tensometry and ECM remodeling. New spatial patterns of interaction between MCs and the immune and stromal landscape may have beneficial effects in developing therapeutic solutions for fibrotic change prevention.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Inflammation: Introduction
Asthma I: Introduction
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
